Loading
institutionsInstitution
Koo Foundation Sun Yat-Sen Cancer Center
Taiwan's first dedicated cancer hospital, founded 1990 on the MD Anderson model and known for multidisciplinary care and outcome transparency.
Also called: KF-SYSCC和信治癌中心醫院
Overview
The Koo Foundation Sun Yat-Sen Cancer Center was established in 1990 by the Koo family with early guidance from MD Anderson and Memorial Sloan Kettering, and was Taiwan's first hospital devoted entirely to cancer. Under founding CEO Andrew Huang it introduced multidisciplinary team care, tumour-board review of every case and public reporting of survival outcomes, and it has been an early adopter of stereotactic radiotherapy, brachytherapy and precision oncology programmes. It is known for breast, head and neck, lung and lymphoma care, for cancer survivorship and palliative services, and for an outsized publication record for its size in health services research and quality of care.
Location
Taipei, TW
Type
cancer center
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#308 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Koo Foundation Sun Yat-Sen Cancer Center, including child institutions. 85 works · 295 citations · 89% open access · 8% clinical trials · 0% reviews.
Oncology works per year
72022
72023
132024
62025
522026
Most works
- Hsieh-Ting Lin41 works
- Shao‐Chin Chiang6 works
- Tran‐Der Tan5 works
- Chiun‐Sheng Huang5 works
- Antonio Gutiérrez4 works
- Francesca Lim4 works
- Melissa Min-Szu Yao4 works
- Sabarish Ayyappan4 works
- Srikanth Ambati4 works
- Amy Ming‐Fang Yen4 works
Most cited
- Multidisciplinary cancer care
- Breast cancer
- Head and neck cancer
- Outcomes reporting
Similar pages
- PersonJoe Y. Chang
Shares MD Anderson Cancer Center, SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer.
- InstitutionRajiv Gandhi Cancer Institute and Research Centre
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- InstitutionIstanbul University Institute of Oncology
Shares Brachytherapy, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- InstitutionHacettepe University Cancer Institute
Shares Brachytherapy, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
- InstitutionHealthCare Global Enterprises
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- TechnologyThe gap between the rehabilitation people need and the rehabilitation they are offered
Shares Survivorship care and late-effects surveillance, Head and neck squamous cell carcinoma, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- JournalLung cancer
Shares Nei-Min Chu, Non-small-cell lung cancer.